68Ga-EV203 imaging for blood cancers
Part of Blood & lymphatic clinical trials.
This trial uses a special imaging agent called 68Ga-EV203 to see where certain blood cancers (multiple myeloma, non-Hodgkin lymphoma, or acute myeloid leukemia) are located in the body. It helps doctors understand how the agent spreads and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old.
- You need to be able to lie still on a scanner bed for about 30 minutes.
- You must have a confirmed diagnosis of multiple myeloma, non-Hodgkin lymphoma, or acute myeloid leukemia.
- You cannot be pregnant, breastfeeding, or planning to become pregnant during the study.
- You must not have had any other cancer treatment within the last 2 weeks, or radiation within the last 8 weeks.
- You must not have a fear of enclosed spaces (claustrophobia) that would prevent you from having the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new PET scan method (using a special tracer called 18F-Pentixafor) to see if it can better find and track blood cancers. It may help your doctors get more detailed images with less radiation.
This trial tests a new PET/CT imaging tracer called [18F]BL40 to see if it can help spot certain types of blood cancers. It may help doctors better understand and monitor these diseases.
This early (Phase 1) study tests how a special scan works in people with relapsed or hard-to-treat leukemia types. The scan uses a tracer called 18F FLT, and the study looks to see if it can be done safely (without sedation) and how it relates to treatment.
This study tests a new PET imaging agent called [68Ga]Ga-ELI411 to help see tumors more clearly. It is for adults with solid tumors who are already scheduled for a standard PET scan, and may help doctors better understand and manage their cancer.
This study uses a special PET scan to look for multiple myeloma in your body. It may help doctors see where the disease is and how active it is.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
Hear when a new Hematological Malignancies B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.